Dolutegravir (DTG) is the only second-generation integrase inhibitor (INI) available in clinical practice. It has advantages in comparison to first generation INIs including unboosted daily dosing, limited cross resistance, and a high barrier to resistance. In clinical trials DTG proved efficacious and safe in naive and experienced patients. However, a recent study in a real life setting reported an unexpectedly high rate of discontinuation mainly due to central nervous system (CNS) events

Dolutegravir tolerability in clinical practice: results from the SCOLTA cohort

G. Pellicanò;
2016-01-01

Abstract

Dolutegravir (DTG) is the only second-generation integrase inhibitor (INI) available in clinical practice. It has advantages in comparison to first generation INIs including unboosted daily dosing, limited cross resistance, and a high barrier to resistance. In clinical trials DTG proved efficacious and safe in naive and experienced patients. However, a recent study in a real life setting reported an unexpectedly high rate of discontinuation mainly due to central nervous system (CNS) events
2016
File in questo prodotto:
File Dimensione Formato  
Poster_230_glasgowfinal.pdf

accesso aperto

Descrizione: Poster
Tipologia: Altro materiale allegato (es. Copertina, Indice, Materiale supplementare, Brevetti, Spin off, Start up, etc.)
Licenza: Creative commons
Dimensione 671.93 kB
Formato Adobe PDF
671.93 kB Adobe PDF Visualizza/Apri
2016-Journal_of_the_International_AIDS_Societ_pp-168-169.pdf

accesso aperto

Descrizione: Meeting Abstract P230
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 279.74 kB
Formato Adobe PDF
279.74 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3128618
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact